Welcome to the Future of Compliance: Navigating the New EU AI Act with Confidence

In the rapidly evolving landscape of medical technology, staying ahead of regulatory changes is paramount. The recently introduced EU AI Act Regulation (EU) 2024/1689 brings a new era of stringent requirements for AI systems in medical devices and in vitro diagnostics (IVDs).

As a manufacturer, you face the dual challenge of innovation and compliance. At regenold GmbH, we specialize in guiding you through these complexities, ensuring your AI-driven solutions not only meet regulatory standards, but also provide added business value for the manufacturer. Our team of seasoned AI specialists is dedicated to empowering you with the knowledge, tools, and strategies necessary for a seamless transition to these new requirements.

Expert Guidance for Seamless Compliance and Innovation

The EU AI Act introduces rigorous conformity assessments for high-risk AI systems, mandating unprecedented levels of transparency, data quality, and human oversight. Navigating these waters can be daunting, but with regenold GmbH by your side, you are not alone. Our comprehensive support services begin with a thorough compliance assessment, identifying any gaps and offering tailored solutions to bridge them. We assist in developing robust data governance frameworks, ensuring your datasets are relevant, representative, and free from bias, thereby enhancing the accuracy and reliability of your AI models.

Ensure Transparency and Human Oversight

Transparency is at the heart of the new regulations. Our experts will help you create clear, detailed documentation and implement transparency mechanisms that keep both regulators and users informed and confident in your technology. We emphasize human oversight, integrating effective monitoring systems that allow for seamless human intervention when necessary. Our collaborative approach includes rigorous internal audits and coordination with third-party evaluators to facilitate smooth conformity assessments.

Achieve Long-Term Success Beyond Compliance

With regenold GmbH, you gain more than just compliance; you gain a strategic partner committed to your success. We offer ongoing post-market surveillance, user feedback mechanisms, and continuous support to ensure your AI systems remain compliant throughout their lifecycle. Our specialized training programs keep your team abreast of the latest regulatory updates, fostering a culture of compliance and innovation within your organization.

Partner with Us for a Confident Transition to EU AI Act Compliance

Join the ranks of forward-thinking medical device and IVD manufacturers who trust regenold GmbH to navigate the complexities of the EU AI Act. Let us transform regulatory challenges into opportunities for growth and excellence. Contact us today to discover how our expert AI specialists can support your journey toward seamless compliance and sustained innovation. Embrace the future of medical technology with confidence and clarity—partner with regenold GmbH and stay ahead of the curve.

We'll be more than happy to answer any questions you might have.

Give us a shout and we'll help you out.

Keep Your Drug-Device Combination Products Variation-Ready

EU Submission Readiness for Global Pharma

Keep Your Drug-Device Combination Products Variation-Ready

Making AI in Pharma Regulatory-Ready From Model to Submission

WELCOME TO THE FUTURE OF COMPLIANCE

Navigating the New EU AI Act with Confidence